Glucagon: Nursing Drug Guide, Severe Hypoglycemia & NCLEX Review
Healthcare medication guide: severe hypoglycemia rescue when oral glucose is unsafe, hepatic glycogen dependence, mandatory follow-up carbohydrates, repeat-dose timing, and when to switch to IV dextrose instead of a second glucagon dose.
Glucagon mobilizes hepatic glycogen to raise blood glucose during severe hypoglycemia when the patient cannot take oral carbohydrates safely. It will not work when glycogen stores are depleted—prolonged fasting, starvation, chronic malnutrition, or adrenal insufficiency. After any response, prescribing information requires oral carbohydrates because glucagon’s effect is transient. If no response occurs, repeat the dose at 15 minutes (1 mg if ≥20 kg; 0.5 mg if <20 kg); if still ineffective, use IV dextrose per prescriber and facility protocol. IV glucagon is for use under medical supervision only.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Glucagon is not a substitute for oral glucose once the patient can swallow safely—and it may fail entirely when hepatic glycogen is gone. After administration, prepare follow-up carbohydrates, recheck glucose at 15 minutes, repeat the dose once if needed, and escalate to IV dextrose when starvation, adrenal insufficiency, or insulinoma is suspected.
Most common brand names
Injectable glucagon for hypoglycemia rescue is supplied as emergency kits containing powder and diluent for reconstitution. Verify the exact kit on the MAR and in the patient’s home supply—not all glucagon products share the same device or storage rules.
Common brands include GlucaGen HypoKit and generic glucagon for injection. Intranasal glucagon (Baqsimi) is a separate rescue formulation; this guide focuses on SC/IM/IV injection kits per the reviewed DailyMed prescribing information. Keep kits where nurses and caregivers can reach them during hypoglycemia emergencies in patients on insulin glargine, insulin lispro, or other insulin regimens.
Why we give it — Indications
Glucagon is an emergency antihypoglycemic used when a patient with insulin-treated type 1 diabetes or type 2 diabetes has severe hypoglycemia and cannot safely take oral carbohydrates— for example with altered consciousness, seizure, or inability to swallow.
| Use | Detail |
|---|---|
| Severe hypoglycemia rescue | Treatment of severe hypoglycemia in adults and pediatric patients when oral glucose is impractical, unsafe, or ineffective per prescribing information. |
| Diagnostic use (specialist) | Glucagonoma testing is a specialist diagnostic indication—outside routine nursing rescue workflow and contraindicated in known glucagonoma when used for that purpose. |
On a small screen, swipe or scroll sideways to see the full table.
How it works
Glucagon is a polypeptide hormone that stimulates hepatic glycogenolysis and gluconeogenesis, raising blood glucose by releasing stored liver glycogen. This mechanism requires adequate hepatic glycogen—so glucagon is unreliable after prolonged fasting, starvation, chronic malnutrition, or adrenal insufficiency. Nurses must therefore pair glucagon rescue with IV dextrose readiness and never assume one dose guarantees sustained normoglycemia.
Dosing overview
Dosing is weight-based for pediatric patients under 20 kg. After any response, give oral carbohydrates when the patient can swallow safely. Repeat once at 15 minutes if no response. Renal or hepatic dose adjustment for hypoglycemia rescue is not specified in the reviewed prescribing information.
Missed dose: Not applicable to PRN rescue use. Document time of each dose and plan the 15-minute reassessment before considering repeat administration.
Onset, peak, duration, and half-life
| Parameter | Value | Nursing relevance |
|---|---|---|
| Onset (SC) | Increase in blood glucose within 10 minutes | Recheck capillary glucose and mental status early; do not leave the patient unattended |
| Peak (SC) | Mean maximum increase ~136 mg/dL at ~30 minutes | Transient rise—oral carbs still required once safe to swallow |
| Peak (IM) | Mean maximum increase ~138 mg/dL at ~26 minutes | IM is acceptable when SC access is limited; rotate documentation of injection site |
| Duration / half-life | Not specified in the reviewed prescribing information for nursing-relevant summary | Plan 15-minute repeat-dose checkpoint and follow-up carbohydrates because effect wanes |
On a small screen, swipe or scroll sideways to see the full table.
Before you give it — Safety check
Pretreatment checks
- Confirm severe hypoglycemia with inability to take oral glucose safely—check capillary glucose and mental status; look for confusion with low sugar, diaphoresis, or seizure
- Verify kit is in date, diluent and powder are paired correctly, and IV dextrose is available if glucagon may fail (fasting, malnutrition, adrenal insufficiency)
- Review recent insulin doses, missed meals, and alcohol use; perform medication reconciliation on admission
Contraindications
- Known hypersensitivity to glucagon or formulation excipients
- Pheochromocytoma and insulinoma (per labeling)
- Glucagonoma when glucagon is used for diagnostic testing
Important interactions
| Drug / class | Effect | Nursing action |
|---|---|---|
| Beta-blockers | Transient increase in pulse and blood pressure; blunted pulse response possible | Monitor BP and heart rate; do not rely on tachycardia alone as proof of response |
| Indomethacin | May block glucagon effect in some patients | Prepare IV dextrose early if patient takes indomethacin and glucagon fails |
| Warfarin | Increased anticoagulant effect reported | Monitor for bleeding if patient receives repeated glucagon; notify prescriber per protocol |
| Insulin | Underlying cause of hypoglycemia—glucagon does not stop insulin action | Follow insulin administration safety and hold/adjust insulin only per prescriber after stabilization |
On a small screen, swipe or scroll sideways to see the full table.
Administration
Route: Subcutaneous, intramuscular, or intravenous (IV only under medical supervision). Reconstitute immediately before use per kit instructions.
- Reconstitute: add diluent to powder vial, swirl gently until clear—do not shake vigorously unless kit instructions specify
- Administer by subcutaneous injection or IM injection into a large muscle (e.g., thigh, deltoid, gluteal) when IM route is chosen
- Position patient safely on side if altered consciousness; protect airway and prepare suction if available per facility protocol
- Once awake and able to swallow, give fast-acting oral carbohydrates followed by longer-acting snack per prescriber/diabetes protocol
Glucagon → recheck glucose at ~15 minutes → repeat dose once if no response → IV dextrose if still hypoglycemic or if glycogen depletion is suspected → oral carbohydrates after sustained improvement when swallowing is safe.
Expected therapeutic response
- Rising capillary blood glucose—SC rise often within 10 minutes; mean peak increase ~136 mg/dL around 30 minutes per labeling
- Improved mental status, return of alertness, cessation of seizure activity when hypoglycemia was the cause
- Patient able to follow commands and swallow oral carbohydrates within the expected timeframe—if not, prepare repeat glucagon or IV dextrose
Red flags — Stop and act
Glucagon rescue fails when nurses miss contraindications, skip follow-up carbohydrates, or delay IV dextrose in glycogen-depleted patients. Escalate immediately.
- No glucose rise or persistent altered mental status 15 minutes after first dose—repeat per labeling, then IV dextrose
- Known or suspected starvation, prolonged fasting, adrenal insufficiency, or chronic malnutrition where hepatic glycogen is unlikely adequate
- Signs of pheochromocytoma crisis or insulinoma after glucagon—hypertension, severe headache, or paradoxical worsening hypoglycemia
- Nausea and vomiting after response preventing oral carbohydrate intake—notify prescriber for alternate glucose route
- Anaphylaxis or severe hypersensitivity after injection—stop and treat per facility anaphylaxis protocol
Adverse effects
| Adverse effect | Frequency / severity | Nursing response |
|---|---|---|
| Nausea, vomiting | Very common after rescue doses | Position for airway protection; give oral carbs only when swallowing is safe; antiemetic per prescriber if needed |
| Injection-site reactions | Common | Document site; rotate sites on repeat doses |
| Headache, dizziness, somnolence, asthenia | Reported in labeling | Monitor neurologic status until glucose stabilizes |
| Pallor, diarrhea, decreased BP | Reported | Monitor vitals; correlate with glucose trend and volume status |
| Transient increased pulse/BP | More likely with beta-blocker co-therapy | Monitor cardiovascular status; BP surge in overdose may need phentolamine per labeling |
| Anaphylaxis | Serious; uncommon | Stop glucagon, treat per anaphylaxis protocol, document and do not rechallenge |
On a small screen, swipe or scroll sideways to see the full table.
Overdose, toxicity, and antidote
Glucagon overdose causes nausea, vomiting, and increased blood pressure and pulse per prescribing information. Dramatic blood pressure elevation may be treated with phentolamine per labeling. Monitor potassium because glucagon can affect electrolytes during large or repeated doses.
Early signs
- Persistent nausea and vomiting after rescue or accidental duplicate dosing
- Tachycardia, hypertension, or pallor disproportionate to hypoglycemia correction
Management
Supportive care, vital sign monitoring, and electrolyte checks—especially potassium. Phentolamine may be used for dramatic BP increase per labeling. Contact prescriber and local poison control or toxicology services per facility protocol for supratherapeutic exposure.
Contact local poison control or medical toxicology services for overdose guidance per facility protocol and local emergency guidance.
Look-alike / sound-alike and error prevention
- Glucagon vs glycopyrrolate (Robinul)—verify drug name on the kit label before reconstitution
- Glucagon vs glucose / dextrose—glucagon mobilizes stored glycogen; IV dextrose provides immediate substrate—do not substitute one for the other in ongoing severe hypoglycemia
- GlucaGen kit vs Baqsimi nasal—different devices, routes, and storage; teach caregivers which product the patient carries
- Expired kit—check expiry on admission, during diabetes education, and before discharge; replace expired home kits before the patient leaves
- Diluent mix-up—use only the diluent supplied with the kit; never reconstitute with normal saline or sterile water unless the specific product labeling directs
- Duplicate dosing—two nurses or a caregiver plus staff may both administer; communicate clearly after the first dose and document time for the 15-minute reassessment
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Reconstitution | Add diluent to powder, swirl until dissolved, administer immediately—practice with the exact kit stocked on your unit. |
| Storage | Store unopened kits at room temperature per labeling; protect from light; do not freeze unless product-specific instructions allow. |
| Kit expiry | Verify expiration on every shift for high-risk inpatients; replace expired kits before discharge teaching. |
| After response | Fast-acting carbs (juice, glucose gel if alert) plus complex carb/protein snack once swallowing is safe. |
| 15-minute rule | Set a timer for glucose recheck and repeat-dose decision—do not assume first dose failed without timed reassessment. |
| Commonly missed | Skipping oral carbs after awakening; not preparing IV dextrose when patient has been NPO or fasting. |
| Ask pharmacy when | Unclear kit type, expired supply, warfarin interaction concern, or repeated glucagon doses in one event. |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Prolonged fasting / starvation / malnutrition | Depleted hepatic glycogen—glucagon may not raise glucose; prioritize IV dextrose. |
| Adrenal insufficiency | Glucagon effect may be inadequate; ensure steroid and glucose rescue pathways are ready. |
| Insulinoma / pheochromocytoma | Contraindicated or dangerous per labeling—escalate to prescriber immediately if suspected. |
| Beta-blocker therapy | Blunted tachycardia may hide stress response—rely on glucose values and mental status. |
| Pregnancy | No identified major risk in available human data per labeling; use for life-threatening hypoglycemia when benefits outweigh risks. |
| Lactation | LactMed: peptide digested in infant GI tract—unlikely clinically significant exposure in breastfed infants. |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Capillary blood glucose before and after glucagon—at least at 10–15 minutes and again after oral carbohydrates
- Neurologic status, airway, and vital signs until sustained improvement
- Nausea/vomiting, BP, pulse, and potassium if repeated doses or overdose concern
- Coordinate outpatient diabetes follow-up—including trend HbA1c when available—after severe hypoglycemia events
Document
- Dose, route, site, time, lot/expiry of kit, and who administered (including caregiver if applicable)
- Pre- and post-treatment glucose values, mental status, and oral carbohydrates given with tolerance
- Prescriber notification, repeat-dose decision, and IV dextrose if glucagon failed
Patient teaching
- Keep an unexpired glucagon kit accessible at home, school, or work when on insulin; teach family when to call emergency services per local guidance
- After any glucagon use, eat fast-acting carbohydrates as soon as swallowing is safe, then a snack—glucagon alone is not enough
- Practice reconstitution before an emergency; replace kits after use or expiration
- Recognize early hypoglycemia and treat with oral glucose when alert—glucagon is for severe events when oral treatment fails
- Contact diabetes team after severe hypoglycemia to review insulin doses, meals, and activity
The Hold Rule
Do not give and contact the prescriber/pharmacist when:
- Known glucagon allergy or prior anaphylaxis to the product
- Suspected pheochromocytoma, insulinoma, or glucagonoma (diagnostic contraindication)
- Patient is alert and can swallow oral carbohydrates safely—oral glucose is first line
- Kit is expired, incomplete, or reconstituted product appears discolored or particulate
- Second repeat dose already given without prescriber guidance—prepare IV dextrose and escalate instead
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Severe hypoglycemia is a time-critical event. Glucagon buys time by mobilizing liver glycogen, but the nurse owns the full rescue arc: safe administration, timed reassessment, mandatory follow-up carbs, and IV dextrose when glycogen is gone.
1. Check-before-you-give protocol
- Confirm severe hypoglycemia and unsafe swallowing before opening the kit
- Verify kit expiry, paired diluent, and weight-based dose (≥20 kg = 1 mg; <20 kg = 0.5 mg)
- Assign a teammate to prepare IV dextrose while the first nurse reconstitutes glucagon
- Start a 15-minute timer for glucose recheck and repeat-dose decision
2. High-alert and safety badge
Emergency rescue medication — time-critical hypoglycemia pathwayTreat glucagon like other emergency medications: clear communication, immediate documentation, and post-event debrief with prescriber and diabetes educator.
3. Clinical workflow: hold and question rules
- If the patient improves enough to swallow before you inject, switch to oral glucose unless prescriber directs otherwise
- If glucose does not rise at 15 minutes, repeat once then escalate to IV dextrose—especially when fasting or malnourished
- Never discharge after glucagon without teaching follow-up carbohydrates and kit replacement
4. Critical teach-back questions
- “After glucagon works, what will you eat and when?” (Patient should name fast-acting carbs immediately when alert, then a snack.)
- “When should your family give glucagon instead of juice?” (Patient should say when unconscious, seizing, or unable to swallow safely.)
5. Care coordination
Pharmacist: Consult for kit selection, warfarin interaction, expired supply replacement, and repeat-dose questions
Prescriber / diabetes team: Notify after any severe hypoglycemia event for insulin adjustment, hypoglycemia precaution review, and outpatient follow-up
🧠 Quick mental checklist
- Is this severe hypoglycemia with unsafe swallowing—or can I give oral glucose now?
- Is the kit in date and reconstituted correctly?
- Could glycogen be depleted (fasting, starvation, adrenal insufficiency)?
- Did I start a 15-minute timer for recheck and possible repeat dose?
- Once awake, did I give oral carbohydrates and document glucose trend?
Glucagon NCLEX practice questions
Practice NCLEX-style clinical judgment practice for glucagon using a tabbed emergency case (MAR, labs, vitals, nursing notes), then priority action, cue recognition, glucose trend interpretation, matrix urgency sorting, documentation cloze, and rescue-failure judgment—recognise cues → analyse → prioritise → act → evaluate outcomes.
Select a tab to view MAR, labs, vitals, and nursing note details for this case.
- Insulin glargine 18 units SC at 2100 (last night)
- Insulin lispro 6 units SC with breakfast — held this morning (NPO for procedure)
- Glucagon emergency kit available on unit; pharmacy profile shows home kit expired 2 months ago
- 0700: capillary glucose 38 mg/dL; patient minimally responsive
- Capillary glucose 38 mg/dL at 0700 (confirmed on second stick)
- Recent HbA1c 8.4% ( outpatient clinic 3 weeks ago)
- Basic metabolic panel from admission yesterday: glucose 142 mg/dL, potassium 4.0 mEq/L, creatinine WNL
- Heart rate 118/min, regular; BP 104/62 mmHg
- Respirations 18/min; SpO2 97% on room air
- Skin cool, diaphoretic; patient opens eyes to voice but cannot follow commands or swallow safely
- 0645: Pre-procedure checklist — patient NPO since midnight for morning endoscopy
- 0700: Nurse preparing glucagon kit; colleague drawing IV dextrose per protocol
- 0705: Family reports patient skipped dinner yesterday because of anxiety about today’s procedure
Answer key & rationale
Frequently asked questions
When should a nurse repeat glucagon if there is no response?
Prescribing information directs repeating 1 mg SC, IM, or IV at 15 minutes if there is no response in adults and children weighing 20 kg or more, and repeating 0.5 mg at 15 minutes in children under 20 kg. If glucagon still fails—especially with starvation, chronic malnutrition, or adrenal insufficiency—switch to IV dextrose per prescriber and facility protocol.
Why must oral carbohydrates be given after glucagon works?
Glucagon raises blood glucose by mobilizing hepatic glycogen, but its effect is transient. Prescribing information requires giving oral carbohydrates to restore glycogen stores and prevent recurrent hypoglycemia once the patient can swallow safely.
When is glucagon contraindicated or unlikely to work?
Glucagon is contraindicated in pheochromocytoma, insulinoma, known hypersensitivity, and glucagonoma when used diagnostically. It is ineffective when hepatic glycogen is depleted—such as with prolonged fasting, starvation, or adrenal insufficiency—so nurses should prepare IV glucose and escalate when rescue fails.
How is glucagon injection reconstituted at the bedside?
Follow the specific kit instructions: typically add diluent to the glucagon powder vial, gently swirl until dissolved, and administer immediately by SC, IM, or IV under medical supervision for IV use. Verify kit expiry, store unopened kits per labeling, and discard reconstituted product per manufacturer directions.
Is glucagon safe during breastfeeding?
LactMed states glucagon is a peptide that would be digested in the infant gastrointestinal tract and is unlikely to reach the bloodstream of a breastfed infant in biologically relevant amounts. No special precautions are required for breastfeeding after maternal glucagon use for hypoglycemia rescue.
What adverse effects should nurses monitor after glucagon?
Common effects include nausea, vomiting, headache, dizziness, injection-site reactions, and transient blood pressure or pulse changes. Beta-blockers may blunt pulse response. Overdose can cause nausea, vomiting, and increased BP or pulse; dramatic BP rise may require phentolamine per labeling, and potassium should be monitored.
References
-
U.S. National Library of Medicine. Glucagon for injection — Full prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15b49500-0aae-4e25-9a1d-709983233cc6
-
Drugs and Lactation Database (LactMed). Glucagon. Bethesda (MD): National Institute of Child Health and Human Development.https://www.ncbi.nlm.nih.gov/books/NBK501922/
-
American Diabetes Association. Hypoglycemia (low blood glucose).https://diabetes.org/living-with-diabetes/hypoglycemia-low-blood-glucose
-
American Diabetes Association. Severe hypoglycemia (low blood glucose).https://diabetes.org/living-with-diabetes/hypoglycemia-low-blood-glucose/severe
-
U.S. National Library of Medicine. Glucagon injection — patient information. MedlinePlus.https://medlineplus.gov/druginfo/meds/a682146.html
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.